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Abstract: The vulva is a particularly common locus of chronic pain with neuropathic 
characteristics that occurs in women of any age, though most women with neuropathic type 
chronic vulvar pain will remain undiagnosed even following multiple physician visits. Here, 
we report on an exemplary case of a middle-aged woman who was referred to the Vulvovaginal 
Disease Clinic with debilitating vulvar burning and itching over the right labium majus that had 
been persisting for 2 years and was considered intractable. Careful history taking and clinical 
examination, followed by electrophysiological assessment through somatosensory evoked poten-
tials was consistent with genitofemoral neuralgia, for which no obvious cause could be identified. 
Adequate pain relief was obtained with a serotonin–noradrenaline reuptake inhibitor and topical 
gabapentin cream. We briefly discuss the epidemiology, diagnosis, and treatment of genitofemoral 
neuralgia and provide a series of clues to guide clinicians in obtaining a presumptive diagnosis 
of specific neuropathic pain syndromes that may underlie chronic vulvar pain. We further aim to 
draw attention to the tremendous burden of chronic, unrecognized vulvar pain.
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Introduction
Neuropathic pain is an umbrella term that has recently been redefined by the 
International Association for the Study of Pain as pain caused by a lesion or disease 
of the somatosensory system,1 thereby encompassing a number of diverse conditions 
and body sites. Although largely underappreciated, the vulva is a particularly common 
locus of chronic pain with neuropathic characteristics in women of any age. In the 
largest community-based study conducted thus far, chronic “unexplained” vulvar 
pain, defined as burning or sharp knife-like pain or pain on contact, that lasted for 
at least 3 months or longer was reported by nearly 7% of women aged 18–64 years 
in a US urban area.2 In spite of this high prevalence, it was also revealed in the latter 
study that no proper diagnosis was provided to a majority of women suffering from 
chronic vulvar pain even following multiple physician visits,2 a finding that has been 
corroborated by several recent US population-based studies.3,4 Here, we report on a 
case of a middle-aged woman with chronic vulvar neuropathic pain that, although 
unique from a clinical perspective, exemplifies the burden of unrecognized chronic 
vulvar pain from a public health view, as discussed further.
Case presentation
A 45-year-old woman was referred to the Vulvovaginal Disease Clinic with debili-
tating vulvar burning and itching over the right labium majus, also causing severely 
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disturbed sleep. Vulvar pain had been persisting for 2 years 
and was considered intractable. Careful history taking 
revealed that she had two vaginal deliveries and was known 
to suffer from Crohn’s disease involving the right hemico-
lon, terminal ileum, and rectum, for which she was treated 
with azathioprine orally and rectally applied mesalazine. 
The patient also had a laparoscopic fallopian tube ligation. 
Finally, she had a history of atopy, and reported occasional 
seasonal allergic rhinitis symptoms.
The patient was initially followed at a regional hospital. 
A blind biopsy was taken from the right labial skin in a derma-
tology practice; it showed no epidermal or dermal anomalies. 
Several topical treatments were initiated empirically, including 
vaginal antibiotic and fungistatic agents and various corticoid 
ointments, without providing relief. During a surgical consult, 
a nodule was detected in the right labium majus and was the 
presumed cause of the chronic pain. It was removed under 
general anesthesia, and had histological features indicative of a 
ruptured hair follicle. As no diagnosis was obtained, the patient 
was also asked to discontinue all medications, including those 
for treatment of Crohn’s disease. The patient was eventually 
referred to our hospital, which is a tertiary referral center.
Careful examination of the vulva and vagina revealed 
neither visible anomalies nor any other findings indicative of 
vulvar inflammatory, infectious, or neoplastic mucocutaneous 
disease. During the clinical exam, the patient was asked to 
point out the pain area, showing the right labiocrural fold, the 
anterior surface of the right labium majus, and right medial 
upper thigh, though burning sensation of the right labium 
majus was the most prominent complaint and was initially 
mentioned by the patient as the only complaint. Tactile sense 
assessment was performed with a piece of cotton wool, a 
cotton-tip swab, and a sharp wooden stick over these areas 
and further compared with the contralateral sites. While 
varied dysesthetic tactile responses were obtained, the overall 
pattern was hypoesthesia upon soft touch and pronounced 
hyperesthesia and allodynia upon sharp touch. Though often 
difficult to differentiate from ilioinguinal neuralgia, this 
particular pattern was highly suggestive of genitofemoral 
neuralgia, involving both the genital and femoral branches 
of the genitofemoral nerve (Figure 1). Maximal passive hip 
flexion further provoked burning over the right labium majus, 
though not the thigh.
Subsequently, electrophysiological examination through 
somatosensory evoked potentials (SSEP) assessment of the 
labia majora was performed. The labia majora were stimu-
lated with bipolar surface electrodes (cathode proximally) at 
an intensity of two times the sensory threshold, with stimulus 
duration of 0.2 ms and a frequency of 2 Hz. Averaging 
256 sweeps, responses were recorded twice to ensure 
reproducibility. Recording was done using needle electrodes, 
with the active electrode placed 2 cm behind the Cz position 
of the International 10–20 system and the reference electrode 
at the Fpz position. The ground electrode was placed over 
the right anterior thigh. Sensitivity was set at 10 µV and 
analysis time at 100 ms. Recordings were performed with 
the Medelec Sapphire device (Vickers Healthcare Co, Wok-
ing, UK). SSEP responses over the right compared to the 
left labium majus showed a prolonged latency (32.2 versus 
29.1 ms corresponding to ∼10% prolongation) and consider-
ably decreased amplitude (0.50 versus 1.58 µV corresponding 
to ∼70% lower amplitude).
Additionally, imaging of the pelvis was conducted 
through magnetic resonance imaging (MRI), whereby T1-, 
T2- and proton density-weighted sequences were obtained, 
though no anomalies could be documented.
Initial pain relief was procured through application 
of a 5% lidocaine patch fit to the right labium majus and 
left in place during daytime for 12 hours a day. While 
providing some attenuation of pain during the day, the 
patient continued to experience severely disturbed sleep. 
Nortriptyline at a daily dose of 25 mg was ill-tolerated 
without any effect on vulvar pain. Venlafaxine was slowly 
titrated, starting with a dose of 37.5 mg and adding up in 
increments of 37.5 mg per day at intervals of 7 days, until 
a daily dose of 150 mg was reached. While reporting mild 
side effects of vivid dreaming and increased transpiration, 
Ilioinguinal nerve
Genitofemoral nerve,
genital branches
Pudendal nerve
Zone vestibulodynia
Figure 1 topography of neuropathic-type chronic vulvar pain.
Notes: The figure shows the anatomy of the female anogenital region, its primary 
cutaneous nerves (white) with accompanying innervation zones (dashed lines), 
and the most common location of vulvodynia, ie, the vulvar vestibule (yellow). 
Cutaneous nerve distribution in this anatomical region is however highly variable 
with numerous anatomical variants having been described, complicating clinical 
diagnosis of neuropathic pain origin in this anatomical region.
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the patient experienced rapid improvement of vulvar pain, 
which allowed her to resume normal sleep at night, after 
2 years of sleep deprivation. She gradually tapered off 
use of the lidocaine patch and reported that she no longer 
experienced vulvar discomfort during activities of daily 
life. In view of the side effects under venlafaxine, the 
treatment regimen was changed to duloxetine 60 mg a 
day, resulting in disappearance of the side effects, while 
maintaining optimal pain relief of the vulva. Discomfort 
over the right thigh, primarily described as itching rather 
than burning, did persist however, for which we initiated a 
compounded topical gabapentin cream in a 6% concentra-
tion formulated in a nonionic cream, resulting in significant 
relief of discomfort over the right thigh. At some point in 
time during follow-up, the patient reported a slight but 
hindering exacerbation of vulvar pain under duloxetine. 
Careful history taking revealed that the pain reoccurred 
following a bicycle day trip, and the patient was therefore 
instructed on vulvar care with emphasis on limiting vul-
var mechanical strain as a known aggravating factor. One 
year after initial assessment, the patient remains pain free 
under continued treatment with duloxetine orally 60 mg a 
day and 6% gabapentin cream applied twice daily. For this 
kind of approach or publication, Ghent University Hospital 
Institutional Review Board approval was not deemed neces-
sary by our institution. Written informed consent from the 
patient was obtained.
Discussion
According to the International Society for the Study of Vul-
vovaginal Disease, vulvar pain can broadly be classified as 
pain related to a specific disorder, either as pain occurring in 
the absence of relevant visible findings or a specific clinically 
identifiable, neurologic disorder.5 Vulvar pain attributable 
to a specific disorder basically encompasses pain resulting 
from infectious disease (eg, herpes genitalis), inflamma-
tory mucocutaneous disease (eg, lichen planus), neoplastic 
disease (eg, squamous cell carcinoma), and neurological 
disease (eg, postherpetic neuralgia).5 In the event that no such 
underlying disease to vulvar pain can be identified, the term 
vulvodynia has been adopted,5 though etymologically refer-
ring to vulvar pain as such. Vulvodynia involves in the vast 
majority of patients mechanical allodynia and hyperalgesia 
of the vaginal vestibular area, thought to relate at least in part 
to marked regional C-fiber hyperinnervation and possibly 
neuroinflammation.6 While the nosology of vulvodynia has 
been a long-standing matter of debate,5,7,8 clearly, the signs 
and symptoms in vulvodynia show considerable overlap 
with neuropathic pain,9 as assessed by available screening 
tools.10
Women presenting with chronic nociceptive vulvar pain 
typically elicit visible epithelial alterations (eg, lichen planus, 
vulvar intraepithelial neoplasia, and genitourinary syndrome 
of menopause) prompting clinical diagnosis, though histo-
pathological confirmation following biopsy might be sought, 
and hence most of these, often older patients, will eventually 
be managed accordingly. Paradoxically, women presenting 
with the more common neuropathic type of chronic vulvar 
pain, resulting from vulvodynia or specific neuropathic pain 
syndromes, usually do not show visible anomalies, and either 
do not seek medical attention or remain undiagnosed even 
following multiple physician visits.3,4,11 A recent population-
based study revealed, for instance, that merely 3% of women 
meeting vulvodynia criteria were actually diagnosed with 
vulvodynia.3
Illustrating this point is the significant diagnostic delay 
observed in the case we presented, as well as the strong 
physician tendency to attribute the pain reported by the patient 
to visible or demonstrable tissue alterations, prompting biopsy 
and surgery, as well as the number of treatments directed 
toward infectious and inflammatory conditions, even though 
no such diagnosis was obtained.
While chronic “unexplained” vulvar pain is a debilitating 
condition affecting a vast number of women of all ages,2 this 
has been mostly attributed to vulvodynia epidemiology, and 
hence it has not been established how often chronic vulvar 
pain is associated with specific neuropathic pain syndromes 
related to neuralgia of the genitofemoral, ilioinguinal, and 
pudendal nerves (Figure 1), though not a rarity at a vulvar 
disease clinic in our experience.
Genitofemoral neuralgia was first described by Magee12 
as genitofemoral causalgia, and subsequently redefined by 
Lyon,13 where the current nomenclature was introduced.14 
Genitofemoral neuralgia in women is almost exclusively 
known as an iatrogenic pain disorder, complicating com-
mon lower abdominal and pelvic surgical procedures such 
as inguinal herniorrhaphy, cesarean section, hysterectomy, 
and lymph node biopsy, as recently and comprehensively 
reviewed by Cesmebasi et al.14 In the original case series by 
Magee,12 there is also mention of an 11-year-old girl who 
developed genitofemoral neuralgia after falling while bicy-
cling, presumably involving direct trauma to the groin by the 
handle bar.13 Murovic et al,15 in their series of ten patients, also 
reported on four patients who developed genitofemoral neu-
ralgia after blunt abdominal trauma. We identified only one 
case report on spontaneous-onset genitofemoral neuralgia, 
Journal of Pain Research 2015:8submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
848
Verstraelen et al
not related to surgery or blunt trauma, involving a 20-year-old 
woman, in which nerve compression was suspected to result 
from tight-fitting clothing.16 Interestingly, also with regard 
to the case presented by us, bicycle riding has also been 
reported as a possible factor evoking genitofemoral neural-
gia.14 Tight-fitting clothing and bicycling are often reported 
as aggravating or evoking factors in patients with vulvodynia 
or neuropathic pain attending our vulvar disease clinic, point-
ing at vulvar mechanical strain through pressure and friction 
as an important aggravating and possibly initiating factor to 
chronic vulvar disease, though this is poorly addressed in 
the medical literature. We cannot explain how the patient 
presented developed genitofemoral neuralgia, though pos-
sibly resulting from a tubal ligation procedure. A relation 
ship with Crohn’s disease could not be established.
The mainstay to the diagnosis of genitofemoral neural-
gia has been the use of selective nerve blocks, as originally 
proposed by Lichtenstein et al.17 Historically, this technique 
involved an essentially blind block near the pubic tubercle, 
distal to the presumed site of injury following most types 
of surgery, and with a considerable potential for injury to 
the surrounding structures at the injection site. Due to the 
retroperitoneal location dorsal to the psoas muscle, the 
genitofemoral nerve has been notoriously difficult to target 
more proximally. Recently, several medical imaging-guided 
transpsoas techniques have been described by use of com-
puted tomography and ultrasound;18–21 magnetic resonance 
neurography-guided nerve blocks are likely to serve as 
another excellent diagnostic tool.22 In case of clinical 
suspicion of genitofemoral, ilioinguinal, or pudendal neu-
ralgia, we initially obtain electrophysiological assessment 
through SSEP, an approach that has not been reported in 
this context in the literature before. We identified one case 
report in which ilioinguinal nerve entrapment was suspected 
through electromyography in a 35-year-old man with acute 
scrotal pain.23 Clearly, the sensitivity of electrophysiological 
approaches needs to be validated in sufficiently large patient 
series; however, it has proven a useful noninvasive first-line 
diagnostic assessment in our experience.
A myriad of therapeutic approaches for genitofemoral 
neuralgia have been described as comprehensively reviewed 
by Cesmebasi et al,14 including ultrasound-guided nerve block 
injections,20,21 various ablative techniques for neurolysis,24 
and genitofemoral neurectomy, recently described through a 
minimally invasive endoscopic retroperitoneal approach.25–27 
It may be acknowledged that neurolysis or neurectomy of the 
genitofemoral nerve may be accompanied by hypoesthesia 
over the labium majus,15 possibly impairing sexual function.28 
Noninvasive, pharmacotherapeutic approaches may provide 
proper pain relief in a substantial proportion of patients. 
A recent systematic review by the Special Interest Group 
on Neuropathic Pain of the International Association for 
the Study of Pain found sufficient evidence to strongly rec-
ommend tricyclic antidepressants, serotonin–noradrenaline 
reuptake inhibitors, pregabalin, and gabapentin as first-line 
treatments in neuropathic pain.29 In the patient presented here, 
as with many other patients presenting with chronic vulvar 
pain, satisfactory pain relief was obtained with serotonin–
noradrenaline reuptake inhibitors and topical gabapentin.
In summary, it is widely observed that although many 
women of all ages suffer from chronic neuropathic type 
vulvar pain, most of these will remain undiagnosed even 
following multiple physician visits. A majority of these 
patients presumably have vulvodynia, while an unknown 
number of women suffer from a specific neuropathic vulvar 
pain condition. Although physicians such as dermatologists, 
urologists, and gynecologists are largely unfamiliar with these 
conditions, several clues to the diagnosis of genitofemoral, 
ilioinguinal, or pudendal neuralgia may be particularly use-
ful in the first- or second-line assessment when confronted 
with the chronic vulvar pain patient (Table 1): 1) careful 
history taking reveals continuous vulvar pain, often reported 
as a burning sensation (though possibly also involving itch, 
tingling, or sharp pain); 2) pain or discomfort is typically uni-
lateral; 3) vulvar pain or discomfort may be most pronounced 
while sitting, and least prominent when lying; 4) clinical and 
Table 1 Clues to vulvar neuralgia diagnosis in the patient with 
chronic vulvar pain
History taking
1. Continuous vulvar pain, possibly disturbing sleep at night
2.  Pain character often described as burning, though possibly also 
involving itch, tingling, or sharp pain
3.  Pain interferes with activities of daily life
4.  Dyspareunia possibly present, but not obligate
5.  Pain often increases upon pressure of friction imposed to the vulvar 
area (pants, sitting, bicycle riding, etc)
6.  Postural gradient in pain intensity may be present: pain most 
pronounced while sitting, less when standing, and least while lying down
Clinical examination
1. Inspection of the vulva does not reveal any relevant anomalies
2.  even if anomalies are observed, these do not necessarily correlate 
with subjective symptoms
3. Pain is typically unilateral
4. Pain conferred to a well-described vulvar area
5. Pain possibly exacerbated by maximal hip flexion
6.  tactile sense testing over the vulvar area referred often reveals 
aberrant sensory responses (in comparison to the contralateral site), 
including allodynia, hyperesthesia, and hypoesthesia
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microbiological analysis does not reveal anomalies, and even 
if anomalies are observed, these do not necessarily correlate 
with subjective symptoms, especially since symptoms are 
unilateral; 5) vulvar pain may be  provoked by maximal hip 
flexion; and 6) tactile sense anomalies may be demonstrated 
by the use of ordinary disposables available in most physician 
offices. Finally, first-line treatment may be initiated accord-
ing to current evidence with tricyclic antidepressants, 
serotonin–noradrenaline reuptake inhibitors, pregabalin, 
and gabapentin, whereby it is crucial to inform the patient 
on the treatment rationale, expected treatment success, and 
possible side effects.
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